Cationorm

an emulsion of above cpds for treatment of dry eye disease

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

1.	Daull, Philippe: 4 articles (12/2018 - 01/2012)
2.	Garrigue, Jean-Sébastien: 3 articles (12/2018 - 03/2016)
3.	Feraille, Laurence: 2 articles (12/2018 - 03/2016)
4.	Raymond, Elisabeth: 1 article (12/2018)
5.	Guenin, Samuel: 1 article (01/2018)
6.	Hamon de Almeida, Valérie: 1 article (01/2018)
7.	Elena, Pierre-Paul: 1 article (03/2016)
8.	Amrane, M: 1 article (10/2014)
9.	Baudouin, C: 1 article (10/2014)
10.	Creuzot-Garcher, C: 1 article (10/2014)

1.	Dry Eye Syndromes (Dry Eye Syndrome) 10/01/2014 - "These results suggest that in patients with mild to moderate dry eye, Cationorm, in addition to its moisturizing and lubricating properties, also helps stabilize the tear film due to its oily component. " 03/01/2016 - "These data position Cationorm as a promising AT for the management of signs and symptoms of dry eye in patients with mild to moderate dry eye disease presenting chronic subclinical levels of ocular inflammation." 12/01/2018 - "The cationic emulsion Cationorm is designed for the management of mild-to-moderate dry eye disease (DED) patients that present cornea epithelium alterations. " 01/01/2018 - "These ATs have recently reached the market as ATs for the management of dry eye disease (DED) symptoms (i.e., Cationorm) or as a drug vehicle for cyclosporine (Ikervis). " 03/01/2016 - "Preservative-free cationic emulsions (eg, Cationorm(®)) are an innovative approach for the management of signs and symptoms of dry eye. "
2.	Inflammation (Inflammations) 03/01/2016 - "These data position Cationorm as a promising AT for the management of signs and symptoms of dry eye in patients with mild to moderate dry eye disease presenting chronic subclinical levels of ocular inflammation."